CARIS LIFE SCIEN. A News

Aktie
WKN:  A41A14 ISIN:  US1421521071 US-Symbol:  CAI Branche:  Biotechnologie Land:  USA
16,85 €
-0,2 €
-1,17%
11:07:57 Uhr
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
35,66%
KGV
-
Index-Zuordnung
-

CARIS LIFE SCIEN. A News

26.02.26 - PR Newswire
/C O R R E C T I O N -- Caris Life Sciences/
/C O R R E C T I O N -- Caris Life Sciences/ PR Newswire
26.02.26 - PR Newswire
Caris Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
Caris Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook PR Newswire
24.02.26 - PR Newswire
Caris Launches Proprietary AI Insights Signature Which Deepens Understanding of Response to Breast Cancer Patients' Oral Chemotherapy Drug
Caris Launches Proprietary AI Insights Signature Which Deepens Understanding of Response to Breast Cancer Patients' Oral Chemotherapy Drug PR Newswire
23.02.26 - PR Newswire
Caris Life Sciences to Participate in the TD Cowen 46th Annual Health Care Conference
Caris Life Sciences to Participate in the TD Cowen 46th Annual Health Care Conference PR Newswire
09.02.26 - PR Newswire
Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26
Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26 PR Newswire
28.01.26 - PR Newswire
Caris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan
Caris Life Sciences' Real-​World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan PR Newswire
12.01.26 - PR Newswire
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results PR Newswire
12.01.26 - PR Newswire
Caris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris Detect
Caris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris Detect PR Newswire
05.01.26 - PR Newswire
Caris Life Sciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Caris Life Sciences to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
19.12.25 - PR Newswire
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute PR Newswire
16.12.25 - PR Newswire
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need PR Newswire
04.12.25 - PR Newswire
Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium PR Newswire
02.12.25 - PR Newswire
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute PR Newswire
21.11.25 - PR Newswire
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class PR Newswire
17.11.25 - PR Newswire
Caris Life Sciences to Attend Q4 2025 Investor Conferences
Caris Life Sciences to Attend Q4 2025 Investor Conferences PR Newswire
05.11.25 - PR Newswire
Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance PR Newswire
29.10.25 - PR Newswire
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response PR Newswire
23.10.25 - PR Newswire
Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025
Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025 PR Newswire
14.10.25 - PR Newswire
Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025
Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025 PR Newswire
15.08.25 - PR Newswire
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek®
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-​Approved MI Cancer Seek® PR Newswire

Newssuche

Videos

newspaper
25.02.26
So beeinflussen Margins DEIN Trading
Börsentäglich ab 18 Uhr Feierabend-​Trading Live. Teilnahme kostenlos mit diesem Link ... Mehr »